{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T01:56:20Z","timestamp":1777514180879,"version":"3.51.4"},"reference-count":15,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Dalhousie Medical Research Foundation Bergmann-Porter Studentship","award":["$5000"],"award-info":[{"award-number":["$5000"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Cutan Med Surg"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Melanoma represents a significant public health challenge in Canada, contributing to the deaths of over 1000 individuals each year. Prince Edward Island and Nova Scotia were previously noted to have the highest incidence rates of melanoma in Canada.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Data from patients diagnosed with or dying from melanoma was extracted from the Nova Scotia Cancer Registry. TNM stage was available for cases diagnosed 2007 to 2017. Incidence (1992-2019) and mortality (1992-2021) rates were examined using Join Point Trend Analysis Software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Between 2007 and 2019, 2450 cases of in situ and 4063 cases of invasive melanoma were documented, of which 52.8% were male. The largest number of cases was from the 60- to 79-year age group. The most common site in females was upper limbs (in situ) and lower limbs (invasive), and for males, face, and neck (in situ), and trunk (invasive). The majority of invasive cases (71.5%) were diagnosed at stage I. Invasive melanoma incidence has been increasing by 2.7% per year since 1992, while in situ disease has increased at a greater rate (4.9% per year). The current estimate of 92% for 5 years of net survival has not changed appreciably over the same period. Survival for late-stage melanoma has shown a modest improvement for patients diagnosed over the period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>With increasing rates of melanoma in Nova Scotia, there is a need for informed education, directed at the public and physicians, around pigmented skin lesions. This would allow the patient to detect atypical melanocytic lesions at an early stage. Sun safety practices in Nova Scotia should continue to be encouraged.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/12034754241301404","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T23:14:33Z","timestamp":1732058073000},"page":"39-42","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in Cutaneous Melanoma in Nova Scotia With a Focus on 2007 to 2019"],"prefix":"10.1177","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8400-6714","authenticated-orcid":false,"given":"Rachel A.","family":"Dorey","sequence":"first","affiliation":[{"name":"Faculty of Medicine, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Walsh","sequence":"additional","affiliation":[{"name":"Nova Scotia Health Cancer Care Program, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Dewar","sequence":"additional","affiliation":[{"name":"Nova Scotia Health Cancer Care Program, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3896-9373","authenticated-orcid":false,"given":"Peter R.","family":"Hull","sequence":"additional","affiliation":[{"name":"Division of Clinical Dermatology and Cutaneous Science, Department of Medicine, Dalhousie University, Halifax, NS, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"e_1_3_2_2_2","volume-title":"Canadian Cancer Statistics 2021","author":"Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada, and the Public Health Agency of Canada","year":"2021","unstructured":"Canadian Cancer Statistics Advisory Committee in collaboration with the Canadian Cancer Society, Statistics Canada, and the Public Health Agency of Canada. Canadian Cancer Statistics 2021. Canadian Cancer Society; 2021."},{"key":"e_1_3_2_3_2","unstructured":"Statistics Canada. Table 13-10-0747-01. Number of New Cases and Age-Standardized Rates of Primary Cancer by Cancer Type and Sex. Accessed October 29 2023. https:\/\/doi.org\/10.25318\/1310074701-eng"},{"key":"e_1_3_2_4_2","unstructured":"Nova Scotia Department of Finance\u2014Statistics. Government of Nova Scotia Canada. June 28 2023. Accessed February 9 2024. https:\/\/novascotia.ca\/finance\/statistics\/archive_news.asp?id=18999&dg=&df=&dto=0&dti=3"},{"key":"e_1_3_2_5_2","unstructured":"Canadian Cancer Registry. Age-standardization: incidence for 01 July 1991. Updated June 2 2023. Accessed February 9 2024. https:\/\/www.statcan.gc.ca\/en\/statistical-programs\/document\/3207_D12_V4"},{"key":"e_1_3_2_6_2","unstructured":"Joinpoint Regression Program Version 5.0.2. Statistical Methodology and Applications Branch Surveillance Research Program National Cancer Institute; 2023."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-19-0125"},{"key":"e_1_3_2_8_2","volume-title":"Cancer Statistics in Nova Scotia: A Focus on 1995-1999","author":"Saint-Jacques N","year":"2002","unstructured":"Saint-Jacques N, MacIntyre M, Dewar R, Johnston G. Cancer Statistics in Nova Scotia: A Focus on 1995-1999. Surveillance and Epidemiology Unit, Cancer Care Nova Scotia; 2002."},{"key":"e_1_3_2_9_2","volume-title":"Canadian Cancer Statistics 2023","author":"Canadian Cancer Statistics Advisory Committee in Collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada","year":"2023","unstructured":"Canadian Cancer Statistics Advisory Committee in Collaboration with the Canadian Cancer Society, Statistics Canada and the Public Health Agency of Canada. Canadian Cancer Statistics 2023. Canadian Cancer Society; 2023."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina58111589"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-985X.2009.00580.x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.830254"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/229255030601400409"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/12034754221108978"},{"key":"e_1_3_2_15_2","first-page":"229","article-title":"Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis","volume":"6","author":"Voss RK","year":"2015","unstructured":"Voss RK, Woods TN, Cromwell KD, Nelson KC, Cormier JN. Improving outcomes in patients with melanoma: strategies to ensure an early diagnosis. Patient Relat Outcome Meas. 2015;6:229-242.","journal-title":"Patient Relat Outcome Meas"},{"key":"e_1_3_2_16_2","first-page":"187","article-title":"When do changes in cancer survival mean progress? The insight from population incidence and mortality","volume":"49","author":"Hyunsoon C","year":"2014","unstructured":"Hyunsoon C, Mariotto AB, Schwartz LM, Luo J, Woloshin S. When do changes in cancer survival mean progress? The insight from population incidence and mortality. J Natl Cancer Inst Monogr. 2014;49:187-197.","journal-title":"J Natl Cancer Inst Monogr"}],"container-title":["Journal of Cutaneous Medicine and Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754241301404","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/12034754241301404","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/12034754241301404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:51:18Z","timestamp":1777391478000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/12034754241301404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["10.1177\/12034754241301404"],"URL":"https:\/\/doi.org\/10.1177\/12034754241301404","relation":{},"ISSN":["1203-4754","1615-7109"],"issn-type":[{"value":"1203-4754","type":"print"},{"value":"1615-7109","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]}}}